GlaxoSmithKline Plc–or simply the GSK–will take advantage of Apple iPhone’s popularity for its rheumatoid arthritis study. The London-based pharmaceutical giant is the Cupertino-based tech behemoth’s biggest clinical study participant in its ResearchKit platform.
ResearchKit, tied with its Health app and other apps that use its API, was first introduced by Apple in 2015. Its main goal is to provide an open source software framework for medical and health research. “It helps doctors and scientists gather data more frequently and accurately from participants using the iPhone,” says Apple in a statement.
In an article published at Bloomberg, GSK says their ResearchKit app will collect data from about three hundred participants over three months. Its scientists will also ask the patients to provide physical and emotional symptoms–such as pain and mood–through their iPhones.
GSK’s app with ResearchKit comes with a guided wrist exercise that uses Apple’s popular smartphone to record the patient’s motion. The data will give the pharma giant a “standardized measurement” across all participants. Hence, scientists working for GSK will use the data for clinical trials design.
The app is named GSK Parade, says the company in a press release, and it is powered by Medidata and POSSIBLE mobile. GSK assures the public that the platform provides a secure environment for patient data. In the app, patients have access to a dashboard containing their personal data. They can share it with their healthcare providers, thus helping GPs provide better conversations for treatment plans.
In March of last year, Apple’s Jeff Williams, the senior vice president of Operations, said the new platform is a powerful tool because the iPhone is in use by hundreds of millions of people around the world already. “We saw an opportunity to have an even greater impact by empowering people to participate in and contribute to medical research,” he added.
Arthritis in America
In the United States, according to the CDC–or the Centers for Disease Control and Prevention–one in two people may develop symptomatic knee OA by age eighty-five years. Furthermore, the health institute warns that two in three people who are considered obese may develop such condition in their lifetime. For hip arthritis, one in four people may develop it by age of eighty-five.
From 2010 to 2012, the CDC estimates that about fifty-two point five million American adults annually were ever told by a doctor that they have some form of arthritis, which may include gout, lupus, or fibromyalgia. Based on the same years, they also estimate that about forty-nine point seven of adults about sixty-five years or older reported doctor-diagnosed arthritis.